Navigation Links
RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder
Date:5/19/2009

SAN FRANCISCO, May 19 /PRNewswire/ -- New data demonstrate that maintenance therapy with RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Treatment (RLAT) significantly delayed the time to relapse compared to placebo in patients with Bipolar I Disorder. Results of the study were presented this week at a major medical meeting.

Bipolar Disorder is a brain disorder that causes unusual shifts in a person's mood, energy and ability to function. It is often characterized by debilitating mood swings from extreme highs (mania) to extreme lows (depression). Type I Bipolar Disorder is characterized based on the occurrence of at least one manic episode, with or without the occurrence of a major depressive episode, and affects approximately one percent of the American adult population in any given year.

A randomized, double-blind, placebo-controlled, long-term study was conducted to evaluate the effect of RISPERDAL(R) CONSTA(R) as maintenance therapy in patients who met DSM-IV criteria for Bipolar I Disorder who were stable on medications or experiencing an acute manic or mixed episode. In the first phase of the study, 303 patients were stabilized on open-label RISPERDAL(R) CONSTA(R) for 26 weeks. In the double-blind phase, patients were randomized to either maintenance therapy with RISPERDAL(R) CONSTA(R) (N=154) or placebo (N=149). The median duration of treatment was nine months for patients in the RISPERDAL(R) CONSTA(R) group and five months for patients in the placebo group. The primary endpoint was time to relapse of any mood episode (depression, mania, or mixed).

Time to relapse was significantly longer in patients receiving RISPERDAL(R) CONSTA(R) monotherapy as compared to placebo (p<0.001). In addition, the rate of relapse during the double-blind treatment phase was lower among patients in the RISPERDAL(R) CONSTA(R) group (30 percent; 42/140) compared with the placebo group (56 percent; 76/135). The med
'/>"/>

SOURCE Janssen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
2. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
3. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
4. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
5. Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
6. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 KaloBios Pharmaceuticals, Inc. (Nasdaq: ... the status of the KB001-A development program, including an ... KB001-A Collaboration Update KaloBios ... Pasteur to regain all rights to KaloBios, KB001-A program. ... into in 2010 has been terminated. Under that collaboration ...
(Date:7/28/2014)... RESTON, Va. , July 28, 2014 /PRNewswire/ ... management services, announced the Company has been awarded ... Medical Support Command (NEMSCOM) and its Deployable Medical ... to enable medical personnel to provide world-class healthcare ... any operating environment across the globe. The five ...
(Date:7/28/2014)... 28, 2014  Array BioPharma Inc. (Nasdaq:   ... fourth quarter and full year of fiscal ... discuss those results on Tuesday, August 12, ... Michael Carruthers , Chief Financial Officer ... 12, 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) 619-6397Pass ...
Breaking Medicine Technology:KaloBios Provides Update on KB001-A Partnership and Clinical Status 2KaloBios Provides Update on KB001-A Partnership and Clinical Status 3KaloBios Provides Update on KB001-A Partnership and Clinical Status 4KaloBios Provides Update on KB001-A Partnership and Clinical Status 5KaloBios Provides Update on KB001-A Partnership and Clinical Status 6Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2
(Date:7/29/2014)... Gout was one called “the disease of kings”. However, ... statement essentially moot since many people of today can dine ... are the resources to deal with such a devious disease ... for it, but the effects of the disease are devastating ... , Alternative medicine specialist and author Joe Barton ...
(Date:7/29/2014)... 2014 Consilium Staffing, Your Partner in Locum ... halfway point of 2014, with strong indications the Irving, Texas-based ... of this year. , “This is a great time to ... Consilium Staffing. , “We are proud of what we ... we are even more excited about how things are shaping ...
(Date:7/29/2014)... Guests at Napa Valley's quintessential luxury resort, Auberge ... experience. The top of each luxurious resort bed is adorned ... expertly crafted, 100% Egyptian cotton white duvets and pillow shams ... closer look, words are woven in the linens that serve ... , Intentional breathing and visualization are keys to relaxing ...
(Date:7/29/2014)... 2014 A Forever Recovery , an ... to a great start and gives them a solid foundation ... of the National Cherry Festival kickoff concert held on July ... was co-sponsored by Miller Lite and in partnership with WKLT ... Bay Side Music Stage presented by Blue Cross Blue Shield ...
(Date:7/29/2014)... 2014 Recently, Stwd.co.uk, a distinguished online supplier ... evening dresses . As a summer special offer, all ... to 70 percent off. All new and old customers can ... are proud to announce the new evening outfits. They want ... “We feel happy to launch the big sale. Our cheap ...
Breaking Medicine News(10 mins):Health News:Gout Natural Remedy Report Review | The Ultimate Secret to Eliminating Gout Naturally – Vinamy.com 2Health News:Consilium Staffing Experiences Significant Revenue Growth 2Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Cheap Prom Dresses Available At Popular Online Store Stwd.co.uk 2
... June 17 The business of recruiting,university students ... technology industries that rely on this talent pool ... skills. Yet many,companies haven,t changed their university recruiting ... Best Practices, LLC - a leading,pharmaceutical research firm., ...
... linked to disease found in Sub-Saharan Africans , , , TUESDAY, ... a herpes virus and an atypical form of type 2 diabetes ... , Researchers in France, writing in the June 18 issue ... , noted a possible tie between the presence of antibodies for ...
... researcher at the Center for Molecular and Behavioral ... the recent recipient of a "2008 Young Investigator ... to Mental Health Research (previously known as the ... NARSAD is the world,s leading donor-supported organization dedicated ...
... (AMA) announced today the re-election of William A. Hazel, ... consecutive term,on the AMA Board of Trustees., "I ... help physicians achieve,our shared goal of providing the best ... Hazel has been a participant in the AMA House ...
... proper use and possible long-term effects of hydroxyurea in ... influencing doctors to avoid prescribing it to those in ... by specialists at Johns Hopkins. , "We know that ... this drug, which is the only one we have ...
... Pennsylvania School of Medicine found that the activation of ... biology leads to an increase in lung stem cells. ... repair after injury or disease. The investigators published their ... in Nature Genetics . , "The current findings ...
Cached Medicine News:Health News:Best Practices: Achieving Excellence in Staffing and Recruiting Methods 2Health News:Study Ties Herpes Virus to Emerging Form of Diabetes 2Health News:Rutgers scientist receives prestigious 'Young Investigator Award' 2Health News:Effective treatment for sickle cell underused by doctors 2Health News:Penn researchers find key developmental pathway activates lung stem cells 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: